Skip to main content
. 2015 Aug 4;9:4259–4268. doi: 10.2147/DDDT.S89976

Figure 4.

Figure 4

Docking simulation between tyrosinase and BPA13 or kojic acid.

Notes: (A) Docking simulation between mushroom tyrosinase and BPA13 shown in magenta. (B) The pharmacophore model generated using the LigandScout 3.1 program indicated possible hydrogen bonding interactions and hydrophobic interactions between tyrosinase residues and BPA13. (C) Docking simulation between tyrosinase and kojic acid, used as a positive control. (D) The pharmacophore model generated using the LigandScout 3.1 program indicated a possible hydrogen bonding interaction between tyrosinase residues and kojic acid.

Abbreviation: BPA, (E)-2-benzoyl-3-(substituted phenyl)acrylonitrile.